GatePass Capital’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$335K Buy
3,697
+168
+5% +$15.3K 0.13% 144
2026
Q1
$362K Buy
3,529
+5
+0.1% +$565 0.17% 129
2025
Q4
$442K Buy
3,524
+178
+5% +$22.7K 0.23% 98
2025
Q3
$448K Sell
3,346
-5
-0.1% -$656 0.26% 90
2025
Q2
$456K Buy
3,351
+14
+0.4% +$1.85K 0.3% 69
2025
Q1
$443K Buy
3,337
+978
+41% +$124K 0.33% 65
2024
Q4
$267K Buy
+2,359
New +$273K 0.29% 73

Other funds holding ABT

GatePass Capital's ABT Position: Q2 2026 in Review

GatePass Capital increased its Abbott (ABT) stake by 4.8% in Q2 2026, buying an estimated $15.3K and bringing the position to 3,697 shares worth $335K. The position accounts for 0.13% of the portfolio, ranked #144.

GatePass Capital first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $456K in Q2 2025. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • GatePass Capital held 3,697 shares of Abbott worth $335K as of Q2 2026.
  • GatePass Capital bought 168 Abbott shares in Q2 2026, an estimated $15.3K.
  • Abbott made up 0.13% of GatePass Capital's portfolio in Q2 2026, its #144 holding.
  • GatePass Capital first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • GatePass Capital's Abbott position peaked at $456K in Q2 2025.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on GatePass Capital's 13F filing for Q2 2026, filed 30 Jul 2026.